HomeAbout
About
Aims & Scope
BMJ Digital Health & AI is a new open access, peer-reviewed journal dedicated to the dissemination of cutting-edge research, critical insights, and significant advancements in the fields of digital health and artificial intelligence in healthcare. The journal will bridge the gap between technology and healthcare, creating a forum for scientists, clinicians, and technologists to present innovative solutions that enhance patient care, optimise healthcare processes, and promote health equity.
BMJ Digital Health & AI encourages the submission of high-quality, original research articles, reviews, and opinion pieces that contribute to the understanding and application of AI and digital technologies in healthcare. The journal promotes interdisciplinary research and welcomes contributions from a wide range of fields including medicine, computer science and public health.
Ownership
BMJ Digital Health & AI is wholly-owned by the BMJ Group.
Editorial Board
For information about the BMJ Digital Health & AI editorial team, please refer to the Editorial Board page.
Journal Information
Ownership
BMJ Digital Health & AI is owned by BMJ Group
Publication Model
Open Access
Frequency
Continuous Publication
Launch date
2024
Peer review model
Single anonymised; the names of reviewers are hidden from the author
Online ISSN
3049-575X
Affiliations
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ Group has been a member since 2009.
Open Access articles in BMJ Digital Health & AI are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.